NKE vs UNH: Which Is the Better Buy?

Side-by-side comparison of NIKE, Inc. and UnitedHealth Group Incorporated β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-07-17.
NIKE, Inc. Β· Consumer Cyclical
$41.05
+45.0% upside to fair value
Grade B High Quality
VS
UnitedHealth Group Incorporated Β· Healthcare
$423.38
+45.0% upside to fair value
Grade B High Quality
QuantHub Verdict
NKE trades at a lower forward P/E (19.6x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric NKE UNH
Current Price $41.05 $423.38
Fair Value Estimate $59.52 $613.90
Upside to Fair Value +45.0% +45.0%
Market Cap $60.7B $384.5B
Forward P/E 19.6x 27.2x
EV / EBITDA 14.2x 13.8x
Price / Sales 1.3x 0.8x
Price / FCF 57.9x 19.6x
Revenue Growth YoY -1.1% +0.4%
Gross Margin 42.9% 18.8%
Operating Margin 8.2% 4.2%
Return on Equity 22.0% 12.4%
Dividend Yield 0% 0%
FCF Yield 1.73% 5.12%
Analyst Consensus Hold Strong Buy
Investment Thesis
NKE β€” NIKE, Inc.
NIKE, Inc. is a leading global athletic footwear and apparel company with a durable competitive moat supported by its strong brand, scale, and global distribution infrastructure. The company is currently led by CEO Elliott Hill, a seasoned Nike veteran who returned in October 2024 to navigate intensifying competition and channel complexity. Despite its market leadership and solid profitability me…
UNH β€” UnitedHealth Group Incorporated
UnitedHealth Group Incorporated operates in the healthcare sector, specifically within medical and healthcare plans, providing a durable business model supported by a strong competitive moat and consistent earnings growth. The company currently trades at a price of $423.38 with a market cap of $359.873 billion, reflecting a valuation that is cheap relative to its five-year history, supported by a…
Accumulation Zones
Metric NKE UNH
Zone Low $44.64 $460.42
Zone High $50.59 $521.81
In Buy Zone? Yes Yes
← NKE Research    UNH Research β†’    All Research